Atlas Trials

Hemophilia A With Inhibitors

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hemophilia A With Inhibitors

RecordFirmDate
A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study) (NCT03093480)Bioverativ, a Sanofi company2017-12-08
Individualizing Hemophilia Bypassing Agent Therapy Utilizing Thromboelastography (NCT03002480)Children's Hospital Los Angeles2017-01-01
A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa (NCT02448680)Laboratoire français de Fractionnement et de Biotechnologies2015-12-07
Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors (NCT02484638)CSL Behring2015-07-23
Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors (NCT02020369)rEVO Biologics2014-04-01
rFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors (NCT01105546)Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico2010-12-01
Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors (NCT00221195)Tulane University School of Medicine2003-06-01
The Malmö International Brother Study (MIBS) (NCT00231751)Skane University Hospital2002-11-01
International Immune Tolerance Study (NCT00212472)New York Presbyterian Hospital2002-07-01

Track Hemophilia A With Inhibitors automatically

Every clearance here is in the API, with alerts when new ones post.